249 related articles for article (PubMed ID: 28617439)
1. Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.
Paul D; Ghorai S; Dinesh US; Shetty P; Chattopadhyay S; Santra MK
Cell Death Dis; 2017 Jun; 8(6):e2882. PubMed ID: 28617439
[TBL] [Abstract][Full Text] [Related]
2. Anaphase-promoting complex/cyclosome-Cdc-20 promotes Zwint-1 degradation.
He Y; Li R; Gu L; Deng H; Zhao Y; Guo Y; Yu S; Wang G
Cell Biochem Funct; 2020 Jun; 38(4):451-459. PubMed ID: 31945194
[TBL] [Abstract][Full Text] [Related]
3. Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.
Choppara S; Malonia SK; Sankaran G; Green MR; Santra MK
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):998-1003. PubMed ID: 29343641
[TBL] [Abstract][Full Text] [Related]
4. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
[TBL] [Abstract][Full Text] [Related]
5. Cdc20 mediates D-box-dependent degradation of Sp100.
Wang R; Li KM; Zhou CH; Xue JL; Ji CN; Chen JZ
Biochem Biophys Res Commun; 2011 Dec; 415(4):702-6. PubMed ID: 22086178
[TBL] [Abstract][Full Text] [Related]
6. Anaphase-promoting complex/cyclosome participates in the acute response to protein-damaging stress.
Ahlskog JK; Björk JK; Elsing AN; Aspelin C; Kallio M; Roos-Mattjus P; Sistonen L
Mol Cell Biol; 2010 Dec; 30(24):5608-20. PubMed ID: 20937767
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
[TBL] [Abstract][Full Text] [Related]
8. Degradation of human RAP80 is cell cycle regulated by Cdc20 and Cdh1 ubiquitin ligases.
Cho HJ; Lee EH; Han SH; Chung HJ; Jeong JH; Kwon J; Kim H
Mol Cancer Res; 2012 May; 10(5):615-25. PubMed ID: 22426463
[TBL] [Abstract][Full Text] [Related]
9. The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20.
Lim HJ; Dimova NV; Tan MK; Sigoillot FD; King RW; Shi Y
Mol Cell Biol; 2013 Nov; 33(21):4166-80. PubMed ID: 23979597
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cdc20 for cancer therapy.
Jeong SM; Bui QT; Kwak M; Lee JY; Lee PC
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188824. PubMed ID: 36243246
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy to block mitotic progression for targeted therapy.
Chi JJ; Li H; Zhou Z; Izquierdo-Ferrer J; Xue Y; Wavelet CM; Schiltz GE; Zhang B; Cristofanilli M; Lu X; Bahar I; Wan Y
EBioMedicine; 2019 Nov; 49():40-54. PubMed ID: 31669221
[TBL] [Abstract][Full Text] [Related]
13. SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity.
Singh S; Sreenath K; Pavithra L; Roy S; Chattopadhyay S
Int J Biochem Cell Biol; 2010 Jul; 42(7):1105-14. PubMed ID: 20097305
[TBL] [Abstract][Full Text] [Related]
14. Cdc20 proteolysis requires p38 MAPK signaling and Cdh1-independent APC/C ubiquitination during spindle assembly checkpoint activation by cadmium.
Yen AH; Yang JL
J Cell Physiol; 2010 May; 223(2):327-34. PubMed ID: 20054826
[TBL] [Abstract][Full Text] [Related]
15. CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65.
Du Y; Zhang M; Liu X; Li Z; Hu M; Tian Y; Lv L; Zhang X; Liu Y; Zhang P; Zhou Y
EMBO Rep; 2021 Sep; 22(9):e52576. PubMed ID: 34382737
[TBL] [Abstract][Full Text] [Related]
16. APC/C (Cdh1) controls the proteasome-mediated degradation of E2F3 during cell cycle exit.
Ping Z; Lim R; Bashir T; Pagano M; Guardavaccaro D
Cell Cycle; 2012 May; 11(10):1999-2005. PubMed ID: 22580460
[TBL] [Abstract][Full Text] [Related]
17. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
Pavithra L; Singh S; Sreenath K; Chattopadhyay S
Int J Biochem Cell Biol; 2009 Apr; 41(4):862-71. PubMed ID: 18822384
[TBL] [Abstract][Full Text] [Related]
19. Targeting Cdc20 as a novel cancer therapeutic strategy.
Wang L; Zhang J; Wan L; Zhou X; Wang Z; Wei W
Pharmacol Ther; 2015 Jul; 151():141-51. PubMed ID: 25850036
[TBL] [Abstract][Full Text] [Related]
20. REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1.
Chun AC; Kok KH; Jin DY
Cell Cycle; 2013 Jan; 12(2):365-78. PubMed ID: 23287467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
